Current Experience and Midterm Follow-up of Immediate-Access Arteriovenous Grafts.

[1]  P. Thomson,et al.  A randomized controlled trial and cost‐effectiveness analysis of early cannulation arteriovenous grafts versus tunneled central venous catheters in patients requiring urgent vascular access for hemodialysis , 2017, Journal of vascular surgery.

[2]  H. Schanzer,et al.  Prospective multicenter study with a 1-year analysis of a new vascular graft used for early cannulation in patients undergoing hemodialysis. , 2015, Journal of vascular surgery.

[3]  M. Makaroun,et al.  Arteriovenous grafts are associated with earlier catheter removal and fewer catheter days in the United States Renal Data System population. , 2015, Journal of vascular surgery.

[4]  N. Inston,et al.  Early Cannulation Grafts for Haemodialysis: A Systematic Review , 2015, The journal of vascular access.

[5]  E. Chemla,et al.  The use of the early cannulation prosthetic graft (Acuseal™) for angioaccess for haemodialysis , 2015, The journal of vascular access.

[6]  G. Piffaretti,et al.  Initial Experience with the Gore® Acuseal Graft for Prosthetic Vascular Access , 2014, The journal of vascular access.

[7]  D. Kingsmore,et al.  Early Cannulation Prosthetic Graft (Acuseal™) for Arteriovenous Access: A useful option to provide a Personal Vascular access Solution , 2014, The journal of vascular access.

[8]  R. Foley,et al.  Vascular access morbidity and mortality: trends of the last decade. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[9]  M. Allon,et al.  When Should a Patient Receive an Arteriovenous Graft Rather Than a Fistula? , 2013, Seminars in dialysis.

[10]  E. Chemla,et al.  Early Cannulation Grafts in Straight Axillo‐Axillary Angioaccesses Avoid Central Catheter Insertions , 2011, Seminars in dialysis.

[11]  E. Gillaspie,et al.  Early Cannulation Prosthetic Graft (Flixene™) for Arteriovenous Access , 2011, The journal of vascular access.

[12]  R. McWilliams,et al.  Central Venous Anatomical Variation: Implications for Venous Access , 2011, The journal of vascular access.

[13]  S. Kakkos,et al.  Long-term complication and patency rates of Vectra and IMPRA Carboflo Vascular Access Grafts with aggressive monitoring, surveillance and endovascular management , 2011, Vascular.

[14]  D. Valenti,et al.  Comparison among Transposed Brachiobasilic, Brachiobrachial Arteriovenous Fistulas and Flixene™ Vascular Graft , 2011, The journal of vascular access.

[15]  A. Lumsden,et al.  The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. , 2008, Journal of vascular surgery.

[16]  S. Kakkos,et al.  Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment. , 2008, Journal of vascular surgery.

[17]  P. Thomson,et al.  Vascular access in haemodialysis patients: a modifiable risk factor for bacteraemia and death. , 2007, QJM : monthly journal of the Association of Physicians.

[18]  D. Gravel,et al.  Prospective Surveillance for Primary Bloodstream Infections Occurring in Canadian Hemodialysis Units , 2002, Infection Control & Hospital Epidemiology.